| Autor: |
Baumer-Mouradian SH; Department of Pediatrics, Children's Corporate Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Hart RJ; Department of Pediatrics, Norton Children's and University of Louisville School of Medicine, Louisville, KY 40202, USA., Visotcky A; Institute for Health and Equity, Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Fraser R; Institute for Health and Equity, Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Prasad S; Department of Pediatrics, Children's Corporate Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Levas M; Department of Pediatrics, Children's Corporate Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Nimmer M; Department of Pediatrics, Children's Corporate Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Brousseau DC; Department of Pediatrics, Children's Corporate Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA. |
| Abstrakt: |
(1) Background: We compared influenza and SARS-CoV-2 vaccine hesitancy levels in Black, Hispanic, and White parents/caregivers and identified barriers and facilitators to vaccine acceptance. (2) Methods: This was a mixed methods study. A cross-sectional survey of ED caregivers presenting with children 6mo−18yo compared vaccine hesitancy levels among diverse caregivers. Six focus groups of survey participants, stratified by caregiver race/ethnicity and caregiver intent to receive SARS-CoV-2 vaccine, assessed facilitators and barriers of vaccination, with thematic coding using the Consolidated Framework for Implementation Research (CFIR). (3) Results: Surveys (n = 589) revealed Black caregivers had significantly higher vaccine hesitancy rates than White caregivers for pediatric influenza (42% versus 21%) and SARS-CoV-2 (63% versus 36%; both p < 0.05). Hispanic caregivers were more hesitant than White caregivers (37% flu and 58% SARS-CoV-2), but this was not significant. Qualitative analysis (n = 23 caregivers) identified barriers including vaccine side effects, lack of necessity, inadequate data/science, and distrust. Facilitators included vaccine convenience, fear of illness, and desire to protect others. (4) Conclusions: Minority caregivers reported higher levels of vaccine hesitancy for influenza and SARS-CoV-2. We identified vaccine facilitators and barriers inclusive of Black and Hispanic caregivers, which may guide interventions designed to equitably improve acceptance of pediatric vaccines. |
